EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER

EORTC 22042	Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and registration study.
EORTC 26081/ NCCTG N0577	Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with Newly Diagnosed Anaplastic Oligodendroglioma or Anaplastic Mixed Glioma with Chromosomal Co-delections of 1p and 19q